A combination of two types of cancer-fighting treatments—the immunotherapy agent pembrolizumab and a nanoparticle-bound form of the chemotherapy drug paclitaxel—may provide an urgently needed new treatment approach for ...
Nov 3, 2022
0
2
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes that go beyond their initial indication for lowering blood sugar levels. In clinical trials, ...
Nov 2, 2023
0
1
In an advance in determining the role of environmental agents in causing cancer, scientists today described development of a long-sought way to use biopsy samples from cancer patients to check on human exposure to substances ...
Sep 9, 2013
0
0
Urologic conditions like urinary tract infections, kidney stones, and prostate cancer are a major economic burden on Americans, resulting in health care costs of close to $40 billion annually, according to a newly released ...
May 18, 2012
0
0
A University of Houston biomedical engineer and his team are reporting the discovery of new biomarkers for early detection of bladder cancer (BC), among the most common cancers diagnosed in men in the U.S. According to the ...
Apr 27, 2023
0
4
There is growing evidence of the need for a separate approach to men's and women's health, according to a men's health expert at the University of Adelaide.
Jun 13, 2012
0
0
Transrectal ultrasound guided biopsy is the gold standard for detecting prostate cancer, but international reports have suggested that the number of risks associated with the procedure is increasing. In a new nationwide population-based ...
Aug 20, 2014
0
0
(HealthDay)—For men with prostate cancer, retreatment with high intensity focused ultrasound is associated with an increase in urinary, but not sexual, side effects, according to a study published in the June issue of The ...
Jun 5, 2014
0
0
Detecting red blood cells in the urine of asymptomatic patients who don't see blood when they urinate (asymptomatic microscopic hematuria) is common but it can signal cancer in the genitourinary system.
Apr 17, 2017
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0
